Pfizer and Allergan said they have put to an end to their merger negotiations by mutual agreement. The decision came after the U.S. Treasury and the Internal Revenues Service (IRS) issued a proposal to introduce new rules that would limit the ability of U.S.-based companies to move their headquarters overseas ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.